SARMs
RAD-140
Shop RAD-140 on KimeraChems · code GUIDE (10% off)Definition
RAD-140, also known as Testolone, is a selective androgen receptor modulator (SARM) originally investigated as a treatment for hypogonadism, a potential male contraceptive aid, and more recently as a candidate treatment for hormone receptor-positive breast cancer. As a SARM, it is designed to bind androgen receptors with high selectivity, producing anabolic effects in muscle and bone tissue while minimizing androgenic activity in organs like the prostate. It carries a notably long half-life of approximately 60 hours, which is relevant to dosing interval discussions in research designs. RAD-140 is considered one of the more potent compounds in the SARM category and is associated with meaningful changes in body composition markers across preclinical and observational contexts.
Mechanism of Action
- Selective androgen receptor binding that activates androgen receptors in muscle and bone tissue with high affinity while exhibiting reduced androgenic activity in tissues like the prostate and skin, which is the core premise of the SARM mechanism.
- Anabolic signaling in skeletal muscle driving nitrogen retention, protein synthesis upregulation, and muscle fiber hypertrophy through AR-mediated gene transcription without the full androgenic burden of traditional androgens.
- Metabolic rate elevation observed in research discussions, with elevated resting energy expenditure signals reported beyond what muscle adaptation alone accounts for in certain model contexts.
- Neuroprotective activity observed in early rodent studies where RAD-140 demonstrated protective effects on neurons, potentially via androgen receptor signaling in brain tissue.
- Endogenous testosterone suppression via HPG axis feedback, with RAD-140 signaling through androgen receptors in a way that reduces LH and FSH output and suppresses natural testosterone production in studied models.
Areas of Investigation
- Muscle mass and strength endpoints with RAD-140 widely regarded as one of the more anabolically potent SARMs available, associated with meaningful recomposition and hypertrophy signals within standard research exposure windows.
- Body composition and aesthetic markers including harder, fuller, and more vascular tissue presentation observed at moderate doses in research discussions, alongside strength output improvements.
- Metabolic and fat loss signaling with elevated metabolism and energy expenditure markers reported in certain model contexts, making it a relevant variable in recomposition research designs.
- Hormone receptor-positive breast cancer research where early clinical investigation has explored RAD-140 as a candidate treatment, with some discussion around its effects on existing estrogenic tissue signaling.
- Prostate safety profiling consistent with the selective androgenic premise, with research suggesting limited prostate stimulation compared to traditional androgens.
- Neuroprotective potential based on preclinical data suggesting androgen receptor activity in neural tissue may confer protective effects relevant to brain health research.
Safety Profile
- Testosterone suppression the most significant concern in research monitoring, with HPG axis suppression requiring consideration of endocrine recovery protocols in study designs involving extended exposure windows.
- Hair loss observed in models with androgenic alopecia predisposition, as androgen receptor activation can accelerate follicle sensitivity even with selective compounds.
- Liver stress possible at higher doses or extended exposure durations, with liver function markers recommended as a standard monitoring variable in research designs.
- Kidney stress reported in some observational contexts, with causation not yet fully established; hydration status and kidney marker monitoring are commonly recommended variables in longer designs.
- Mood and behavioral changes including irritability and increased aggression signals in some model contexts, with individual variability noted across research discussions.
- Cardiovascular effects including potential blood pressure elevation and lipid profile shifts that are standard monitoring endpoints, particularly relevant in designs involving subjects with pre-existing cardiovascular markers.
- Joint stress reported in some observational contexts, with concurrent joint support compound inclusion commonly discussed in multi-variable research designs.
- Unknown long-term effects as RAD-140 remains a relatively new compound with limited long-term safety data available outside of early clinical contexts.
Disclaimer
For educational purposes only. Not for human consumption.